IGF1R and rhabdomyosarcoma: However, rapamycin cannot influence the upstream regulators of mTOR, which is in contrast to the research from Wan et al. [39], who showed that rapamycin can activate Akt signalling through an IGF-1R-dependent mechanism in human rhabdomyosarcoma cell lines.